U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. Cellular & Gene Therapy Products
  4. CBER Regenerative Medicine Advanced Therapy (RMAT) Designations Withdrawn after Granting or Rescinded by Fiscal Year
  1. Cellular & Gene Therapy Products

CBER Regenerative Medicine Advanced Therapy (RMAT) Designations Withdrawn after Granting or Rescinded by Fiscal Year

Cohort: December 13, 2016 - September 30, 2024

Data as of June 30, 2024

Fiscal Year Withdrawn After Granting Rescinded
2017 0 0
2018 0 0
2019 0 0
2020 0 0
2021 0 0
2022 0 0
2023 0 0
2024 0 0

* RMAT designation was enacted in the 21st Century Cures Act on December 13, 2016.


Resources for You

Back to Top